Latest News of MNKD
MannKind (MNKD) Q3 2024 Earnings Call Transcript
By Yahoo! Finance |
2 weeks ago
The Motley Fool Stock Advisor team identified the 10 best stocks for investors, excluding MannKind. MannKind is focusing on developing innovative treatments for diseases like NTM lung disease and IPF....
MannKind Corporation (MNKD): Short Seller Sentiment is Bearish
By Yahoo! Finance |
2 months ago
Insider Monkey analyzed the 14 worst 52-week high stocks to buy according to short sellers, focusing on MannKind Corporation (NASDAQ:MNKD). With the US Federal Reserve's rate cuts, the economy faces c...
MannKind Corporation (MNKD): Short Seller Sentiment is Bearish on This Cancer Stock
By Yahoo! Finance |
2 months ago
A compilation of the 10 worst cancer stocks according to short sellers includes MannKind Corporation (NASDAQ:MNKD). The global cancer burden is rising, with the oncology market projected to surpass $5...
-
Is There An Opportunity With MannKind Corporation's (NASDAQ:MNKD) 49% Undervaluation?
By Yahoo! Finance | 4 months agoAnalysts project MNKD's fair value at $6.25, 47% below the current price. Using a two-stage DCF model, the intrinsic value is estimated at $3.2b, indicating a 49% undervaluation....
-
Recent 5.2% pullback isn't enough to hurt long-term MannKind (NASDAQ:MNKD) shareholders, they're still up 327% over 5 years
By Yahoo! Finance | 5 months agoInvesting in great businesses for the long term can be life-changing. MannKind Corporation (NASDAQ: MNKD) has seen a 327% increase in share price over five years, showing the value some businesses can...